# Using Non-invasive Brain Stimulation (tDCS) With Varenicline for Treating Tobacco Dependence

> **NCT03841292** · NA · COMPLETED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 41 (actual)

## Conditions studied

- Tobacco Dependence
- Smoking Cessation
- Tobacco Smoking
- Tobacco Use Disorder
- Substance Use Disorders
- Molecular Mechanisms of Pharmacological Action
- Physiological Effects of Drugs

## Interventions

- **DRUG:** Varenicline
- **DEVICE:** Active tDCS
- **DEVICE:** Sham tDCS

## Key facts

- **NCT ID:** NCT03841292
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-01-31
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2022-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03841292

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03841292, "Using Non-invasive Brain Stimulation (tDCS) With Varenicline for Treating Tobacco Dependence". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03841292. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*